Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (6) | Back to Search
The lfcs consortium: in vitro dispersion tests are an effective first screen during lipid-based formulation development and evaluation
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-067
- By: POUTON, Colin (Monash University, Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
- Co-author(s): Williams, Hywel (Monash University, Parkville, Australia)
Anby, Mette (Monash University, Parkville, Australia)
Mcevoy, Claire (Monash University, Parkville, Australia)
Thomas, Nicky (University of Copenhagen, Copenhagen, Denmark)
Calderone, Marilyn (Sanofi R&D, Montpellier, France)
Igonin, Annabel (Capsugel, Illkirch, France)
Vertommen, Jan (Capsugel, Illkirch, France)
Blundell, Ross (Sanofi R&D, Montpellier, France)
Benameur, Hassan (Capsugel, Illkirch, France)
Mullertz, Anette (University of Copenhagen, Copenhagen, Denmark)
Porter, Chris (Monash University, Parkville, Australia) - Abstract:
I. Background: The LFCS Consortium looks to establish standardized in vitro performance tests for lipid-based formulations (LBF).
II. Aims: Here we evaluate the performance of four LBFs containing danazol (DAN), fenofibrate (FFB), tolfenamic acid (TA) or cinnarizine (CIN) on dispersion using different test conditions.
III. Methods: Dispersion.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023